Travere Therapeutics Presents at Four Upcoming Investor Conferences
- Travere Therapeutics will present at the Guggenheim Global Healthcare Conference on Nov. 10, 2026, at 8:00 a.m. ET.
- Management will participate in the Stifel 2026 Healthcare Conference on Nov. 11, 2026, at 3:20 p.m. ET.
- The UBS Global Biopharma Conference presentation is scheduled for Nov. 16, 2026, at 11:20 a.m. GMT.
- A presentation at the Jefferies London Healthcare Conference follows on Nov. 17, 2026, at 8:00 a.m. GMT.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Travere Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611031630BIZWIRE_USPR_____20261103_BW317035) on November 03, 2026, and is solely responsible for the information contained therein.